Late Relapse After Allogeneic Bone Marrow Transplant In a Patient With Myelodysplasia

Abstract

Bone Marrow Transplantation remains the only potentially curative procedure for patients with Myelodysplastic syndrome (MDS). Patients who remain disease free 5 years after transplantation have usually been considered cured, but more recent experience challenges this expectation. We report here a case of MDS who relapsed more than 5 years following transplant, and was then successfully treated with a second transplant.

Keywords:

• Myelodysplasia
• Allogeneic Bone Marrow Transplant
• Relapse